Based on the described phenotype of CRC in LS patients, alterations in MLH1 and MSH2 are associated with higher incidences of CRC, as well as earlier onset, compared to alterations in MSH6 and PMS2 [37,38]. This evidence concerns the gene MSH2 and colorectal carcinoma.